SCHEMBL23328674

SCHEMBL23328674

CN(C)c1ccc(NC(=O)NCS(=O)(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.58
HDAC4 P56524 2/20 0.58
HDAC1 Q13547 2/20 0.58
HDAC7 Q8WUI4 2/20 0.58
HDAC2 Q92769 2/20 0.58
HDAC10 Q969S8 2/20 0.58
HDAC11 Q96DB2 2/20 0.58
HDAC8 Q9BY41 2/20 0.58
HDAC6 Q9UBN7 2/20 0.58
HDAC9 Q9UKV0 2/20 0.58
HDAC5 Q9UQL6 2/20 0.58
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
CNR1 P21554 1/20 0.53
RAB9A P51151 7/20 0.53
NOX1 Q9Y5S8 6/20 0.53
MAPT P10636 6/20 0.53
NPC1 O15118 5/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23328675 0.84 MAPT (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL25840768 0.82 NPC1 (0.60) CA12CA1CA2CA9CNR1
SCHEMBL16363832 0.80 NOX1 (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29663991 0.79 RAB9A (0.76) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23328727 0.79 RAB9A (0.60) CA12CA1CA2CA9RAB9A
SCHEMBL23329075 0.79 SAE1 (0.50) CA12CA1CA2CA9CNR1
SCHEMBL11057102 0.78 CA1 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23328367 0.78 ACP1 (0.59) HDAC1HDAC8HDAC6CA12CA1
SCHEMBL23328366 0.78 RAB9A (0.64) CA12CA1CA2CA9CNR1
SCHEMBL28800706 0.78 HDAC3 (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS KENT INNOVATION & ENTERPRISE, UNIVERSITY OF KENT (GB) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 HDAC3 1194/4885HDAC4 873/4885HDAC1 316/4885
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS ARF1, ARL1, TLR1 HDAC3 1194/4885HDAC4 873/4885HDAC1 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.